TY - JOUR AU - Wilkinson-Berka, Jennifer L. AU - Deliyanti, Devy PY - 2016 TI - The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies JF - Annals of Translational Medicine; Vol 4, Supplement 1 (October 31, 2016): Annals of Translational Medicine Y2 - 2016 KW - N2 - Ocular neovascularization and vascular leakage are major causes of vision loss and blindness and hallmark features of retinopathy of prematurity (ROP), proliferative diabetic retinopathy (PDR) and neovascular age-related macular degeneration (AMD) (1-3). These diseases comprise a significant global health burden. For instance, it is predicted that by 2035 over 592 million people will be diagnosed with diabetes and by 2040 around 288 million individuals will have AMD (4,5). UR - https://atm.amegroups.org/article/view/12031